
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction
Tingting Wang, JN Rashida Gnanaprakasam, Xuyong Chen, et al.
Nature Metabolism (2020) Vol. 2, Iss. 7, pp. 635-647
Open Access | Times Cited: 226
Tingting Wang, JN Rashida Gnanaprakasam, Xuyong Chen, et al.
Nature Metabolism (2020) Vol. 2, Iss. 7, pp. 635-647
Open Access | Times Cited: 226
Showing 1-25 of 226 citing articles:
CD8+ T cell metabolism in infection and cancer
Miguel Reina‐Campos, Nicole E. Scharping, Ananda W. Goldrath
Nature reviews. Immunology (2021) Vol. 21, Iss. 11, pp. 718-738
Open Access | Times Cited: 382
Miguel Reina‐Campos, Nicole E. Scharping, Ananda W. Goldrath
Nature reviews. Immunology (2021) Vol. 21, Iss. 11, pp. 718-738
Open Access | Times Cited: 382
Gut microbiota in colorectal cancer development and therapy
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 288
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 288
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
Yuting Lu, Xiangliang Yuan, Miao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 279
Yuting Lu, Xiangliang Yuan, Miao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 279
Metabolic adaptation of lymphocytes in immunity and disease
Nicole M. Chapman, Hongbo Chi
Immunity (2022) Vol. 55, Iss. 1, pp. 14-30
Open Access | Times Cited: 187
Nicole M. Chapman, Hongbo Chi
Immunity (2022) Vol. 55, Iss. 1, pp. 14-30
Open Access | Times Cited: 187
Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Yu
Gut (2022) Vol. 71, Iss. 7, pp. 1412-1425
Open Access | Times Cited: 173
Nick Lung-Ngai Ting, Harry Cheuk-Hay Lau, Jun Yu
Gut (2022) Vol. 71, Iss. 7, pp. 1412-1425
Open Access | Times Cited: 173
CD8+ T cells in the cancer-immunity cycle
Josephine R. Giles, Anna-Maria Globig, Susan M. Kaech, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2231-2253
Open Access | Times Cited: 161
Josephine R. Giles, Anna-Maria Globig, Susan M. Kaech, et al.
Immunity (2023) Vol. 56, Iss. 10, pp. 2231-2253
Open Access | Times Cited: 161
Targeting the gut microbiota for cancer therapy
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 149
Miriam R. Fernandes, Poonam Aggarwal, Raquel Costa, et al.
Nature reviews. Cancer (2022) Vol. 22, Iss. 12, pp. 703-722
Closed Access | Times Cited: 149
Advancing to the era of cancer immunotherapy
Yun Wang, Min Wang, Hao‐Xiang Wu, et al.
Cancer Communications (2021) Vol. 41, Iss. 9, pp. 803-829
Open Access | Times Cited: 131
Yun Wang, Min Wang, Hao‐Xiang Wu, et al.
Cancer Communications (2021) Vol. 41, Iss. 9, pp. 803-829
Open Access | Times Cited: 131
New Insights Into the Cancer–Microbiome–Immune Axis: Decrypting a Decade of Discoveries
Tejeshwar Jain, Prateek Sharma, Abhi C. Are, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 130
Tejeshwar Jain, Prateek Sharma, Abhi C. Are, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 130
A guide to interrogating immunometabolism
Kelsey Voss, Hanna S. Hong, Jackie E. Bader, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 10, pp. 637-652
Open Access | Times Cited: 121
Kelsey Voss, Hanna S. Hong, Jackie E. Bader, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 10, pp. 637-652
Open Access | Times Cited: 121
Colorectal cancer: the facts in the case of the microbiota
Slater L. Clay, Diogo Fonseca‐Pereira, Wendy S. Garrett
Journal of Clinical Investigation (2022) Vol. 132, Iss. 4
Open Access | Times Cited: 110
Slater L. Clay, Diogo Fonseca‐Pereira, Wendy S. Garrett
Journal of Clinical Investigation (2022) Vol. 132, Iss. 4
Open Access | Times Cited: 110
Carbon source availability drives nutrient utilization in CD8+ T cells
Irem Kaymak, Katarzyna M. Luda, Lauren R. Duimstra, et al.
Cell Metabolism (2022) Vol. 34, Iss. 9, pp. 1298-1311.e6
Open Access | Times Cited: 109
Irem Kaymak, Katarzyna M. Luda, Lauren R. Duimstra, et al.
Cell Metabolism (2022) Vol. 34, Iss. 9, pp. 1298-1311.e6
Open Access | Times Cited: 109
The gut microbiome: what the oncologist ought to know
Karla A. Lee, Marilan Luong, Heather Shaw, et al.
British Journal of Cancer (2021) Vol. 125, Iss. 9, pp. 1197-1209
Open Access | Times Cited: 107
Karla A. Lee, Marilan Luong, Heather Shaw, et al.
British Journal of Cancer (2021) Vol. 125, Iss. 9, pp. 1197-1209
Open Access | Times Cited: 107
Catalytical nano-immunocomplexes for remote-controlled sono-metabolic checkpoint trimodal cancer therapy
Chi Zhang, Jingsheng Huang, Ziling Zeng, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 103
Chi Zhang, Jingsheng Huang, Ziling Zeng, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 103
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain
Gennady G. Yegutkin, Detlev Boison
Pharmacological Reviews (2022) Vol. 74, Iss. 3, pp. 799-824
Open Access | Times Cited: 91
Gennady G. Yegutkin, Detlev Boison
Pharmacological Reviews (2022) Vol. 74, Iss. 3, pp. 799-824
Open Access | Times Cited: 91
Uridine-derived ribose fuels glucose-restricted pancreatic cancer
Zeribe C. Nwosu, Matthew H. Ward, Peter Sajjakulnukit, et al.
Nature (2023) Vol. 618, Iss. 7963, pp. 151-158
Open Access | Times Cited: 83
Zeribe C. Nwosu, Matthew H. Ward, Peter Sajjakulnukit, et al.
Nature (2023) Vol. 618, Iss. 7963, pp. 151-158
Open Access | Times Cited: 83
Bifidobacterium mechanisms of immune modulation and tolerance
Samuel J. Gavzy, Allison Kensiski, Zachariah L Lee, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 71
Samuel J. Gavzy, Allison Kensiski, Zachariah L Lee, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 71
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 66
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 66
Harnessing innate immune pathways for therapeutic advancement in cancer
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 54
An-Kang Hu, Li Sun, Hao Lin, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 54
Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions
Owen S. Skinner, Joan Blanco-Fernández, Russell P. Goodman, et al.
Nature Metabolism (2023) Vol. 5, Iss. 5, pp. 765-776
Open Access | Times Cited: 53
Owen S. Skinner, Joan Blanco-Fernández, Russell P. Goodman, et al.
Nature Metabolism (2023) Vol. 5, Iss. 5, pp. 765-776
Open Access | Times Cited: 53
Asparagine restriction enhances CD8+ T cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress response
JN Rashida Gnanaprakasam, Bhavana Kushwaha, Lingling Liu, et al.
Nature Metabolism (2023) Vol. 5, Iss. 8, pp. 1423-1439
Open Access | Times Cited: 49
JN Rashida Gnanaprakasam, Bhavana Kushwaha, Lingling Liu, et al.
Nature Metabolism (2023) Vol. 5, Iss. 8, pp. 1423-1439
Open Access | Times Cited: 49
Inosine induces stemness features in CAR-T cells and enhances potency
Dorota D. Klysz, Carley Fowler, Meena Malipatlolla, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 266-282.e8
Open Access | Times Cited: 49
Dorota D. Klysz, Carley Fowler, Meena Malipatlolla, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 266-282.e8
Open Access | Times Cited: 49
Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 41
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 41
Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 41
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 41
Critical role of the gut microbiota in immune responses and cancer immunotherapy
Ze-Hua Li, Weixi Xiong, Liang Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 34
Ze-Hua Li, Weixi Xiong, Liang Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 34